Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manu Anantpadma

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Plos Pathogens|December 23, 2024
Discovery of Nanosota-EB1 and -EB2 as Novel Nanobody Inhibitors Against Ebola Virus InfectionFan Bu, Gang Ye, Kimberly Morsheimer, et al.
Journal of Medicinal Chemistry|September 4, 2020
Screening and Reverse-Engineering of Estrogen Receptor Ligands as Potent Pan-Filovirus InhibitorsLaura Cooper, Adam Schafer, Yangfeng Li, et al.
Plos Pathogens|November 13, 2015
Interferon-γ Inhibits Ebola Virus InfectionBethany A Rhein, Linda S Powers, Kai Rogers, et al.
Antimicrobial Agents and Chemotherapy|May 11, 2016
Large-Scale Screening and Identification of Novel Ebola Virus and Marburg Virus Entry InhibitorsManu Anantpadma, Jennifer Kouznetsova, Hang Wang, et al.
Science Translational Medicine|April 15, 2026
The virus entry inhibitor ARN-75039 provides therapeutic protection against Lassa virus infection in guinea pigsElizabeth Eudy, Daniel Woodburn, Rebecca Reeder, et al.
Antiviral Research|August 26, 2018
Inhibiting pyrimidine biosynthesis impairs Ebola virus replication through depletion of nucleoside pools and activation of innate immune responsesPriya Luthra, Jacinth Naidoo, Colette A Pietzsch, et al.
Antiviral Research|February 19, 2025
Recombinant Pichinde reporter virus as a safe and suitable surrogate for high-throughput antiviral screening against highly pathogenic arenavirusesCarolina Q Sacramento, Ryan Bott, Qinfeng Huang, et al.
Transfusion|March 23, 2016
Treatment of blood with a pathogen reduction technology using ultraviolet light and riboflavin inactivates Ebola virus in vitroAndrew P Cap, Heather F Pidcoke, Shawn D Keil, et al.
Nature Communications|December 10, 2025
Replicon-based genome-wide CRISPR knockout screening for the identification of host factors involved in viral replicationKaren W Cheng, Madhura Bhave, Andrew L Markhard, et al.
Antimicrobial Agents and Chemotherapy|May 18, 2016
Discovery of a Broad-Spectrum Antiviral Compound That Inhibits Pyrimidine Biosynthesis and Establishes a Type 1 Interferon-Independent Antiviral StateDong-Hoon Chung, Jennifer E Golden, Robert S Adcock, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Plos Pathogens|December 23, 2024
Discovery of Nanosota-EB1 and -EB2 as Novel Nanobody Inhibitors Against Ebola Virus InfectionFan Bu, Gang Ye, Kimberly Morsheimer, et al.
Journal of Medicinal Chemistry|September 4, 2020
Screening and Reverse-Engineering of Estrogen Receptor Ligands as Potent Pan-Filovirus InhibitorsLaura Cooper, Adam Schafer, Yangfeng Li, et al.
Plos Pathogens|November 13, 2015
Interferon-γ Inhibits Ebola Virus InfectionBethany A Rhein, Linda S Powers, Kai Rogers, et al.
Antimicrobial Agents and Chemotherapy|May 11, 2016
Large-Scale Screening and Identification of Novel Ebola Virus and Marburg Virus Entry InhibitorsManu Anantpadma, Jennifer Kouznetsova, Hang Wang, et al.
Science Translational Medicine|April 15, 2026
The virus entry inhibitor ARN-75039 provides therapeutic protection against Lassa virus infection in guinea pigsElizabeth Eudy, Daniel Woodburn, Rebecca Reeder, et al.
Antiviral Research|August 26, 2018
Inhibiting pyrimidine biosynthesis impairs Ebola virus replication through depletion of nucleoside pools and activation of innate immune responsesPriya Luthra, Jacinth Naidoo, Colette A Pietzsch, et al.
Antiviral Research|February 19, 2025
Recombinant Pichinde reporter virus as a safe and suitable surrogate for high-throughput antiviral screening against highly pathogenic arenavirusesCarolina Q Sacramento, Ryan Bott, Qinfeng Huang, et al.
Transfusion|March 23, 2016
Treatment of blood with a pathogen reduction technology using ultraviolet light and riboflavin inactivates Ebola virus in vitroAndrew P Cap, Heather F Pidcoke, Shawn D Keil, et al.
Nature Communications|December 10, 2025
Replicon-based genome-wide CRISPR knockout screening for the identification of host factors involved in viral replicationKaren W Cheng, Madhura Bhave, Andrew L Markhard, et al.
Antimicrobial Agents and Chemotherapy|May 18, 2016
Discovery of a Broad-Spectrum Antiviral Compound That Inhibits Pyrimidine Biosynthesis and Establishes a Type 1 Interferon-Independent Antiviral StateDong-Hoon Chung, Jennifer E Golden, Robert S Adcock, et al.
Pageof 4